Farmakologisk behandling af gammahydroxybutyratabstinenssyndrom

Niels August Willer Strand, Tonny Studsgaard Petersen, Lars Martin Nielsen, Soren Boegevig


Gamma-hydroxybutyrate (GHB) is a drug of abuse, for which physical addiction develops quickly. GHB withdrawal can develop into a life-threatening condition and has previously been treated mainly with benzodiazepines. These have not always proven effective, leading to long hospitalizations in intensive care units. Based on successful Dutch treatment results for using GHB to treat GHB withdrawal symptoms, we propose to implement a similar method in Denmark. The method requires an interdisciplinary effort for which The Danish Poison Information Centre should be consulted for expertise.

Bidragets oversatte titelTreatment of gamma-hydroxybutyrate withdrawal
TidsskriftUgeskrift for Laeger
Udgave nummer50
StatusUdgivet - 11 dec. 2017


Dyk ned i forskningsemnerne om 'Farmakologisk behandling af gammahydroxybutyratabstinenssyndrom'. Sammen danner de et unikt fingeraftryk.